Robert David Francis - 26 Jun 2026 Form 4 Insider Report for PROASSURANCE CORP (PRA)

Reporting relationship: Pres Healthcare Pro. Liability
Issuer ticker: PRA
Reported as of: 26 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Jun 2026, 12:19:17 UTC
Prior SEC filing: 26 Feb 2026
Source filing: View source filing
Reporting owner signature: Lee M. Pope POA for Reporting Person

Key filing fact

Robert David Francis filed Form 4 for PROASSURANCE CORP (PRA) on 26 Jun 2026.

Key facts

This page summarizes Robert David Francis's Form 4 filing for PROASSURANCE CORP (PRA).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 26 Jun 2026, 12:19.

Change

Previous filing in this sequence was filed on 26 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001983910 Primary reporting owner

FRANCIS ROBERT DAVID

Relationship: Pres Healthcare Pro. Liability
Address: 100 BROOKWOOD PLACE, BIRMINGHAM
Signature: Lee M. Pope POA for Reporting Person
Signature date: 26 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRA transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -31,196
Change %: -100%
Price: $25.00^*
Shares after: 0
Date: 26 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRA transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares: -23,720
Change %: -100%
Price
Shares after: 0
Date: 26 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,720
Exercise price
Footnotes: F1, F3, F4

PRA transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares: -8,764
Change %: -100%
Price
Shares after: 0
Date: 26 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,764
Exercise price
Footnotes: F1, F3, F4

PRA transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares: -11,778
Change %: -100%
Price
Shares after: 0
Date: 26 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,778
Exercise price
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Robert David Francis is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

On June 26, 2026, pursuant to that certain Agreement and Plan of Merger, dated as of March 19, 2025 (the "Merger Agreement"), among ProAssurance Corporation (the "Issuer"), The Doctors Company ("Parent") and Jackson Acquisition Corporation, a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent.

Footnote F2

At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") that was issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive $25.00 per share in cash, without interest, and subject to any applicable withholding taxes (the "Merger Consideration").

Footnote F3

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock.

Footnote F4

Represents outstanding unvested RSUs (other than certain excluded RSUs, which were forfeited at the Effective Time in accordance with their terms). At the Effective Time, upon the terms and subject to the conditions set forth in the Merger Agreement, the outstanding, unvested time-based and performance-based RSUs (other than the excluded RSUs) automatically and immediately vested and were cancelled and entitled the holder to receive an amount in cash, without interest, equal to the product of (a) the total number of shares of Common Stock subject to the RSUs immediately prior to the Effective Time, multiplied by (b) the Merger Consideration.